Southeast Eye Specialists

Southeast Eye Specialists

Southeast Eye Specialists operates as a multi-location ophthalmology and optometry practice headquartered in Chattanooga, Tennessee. The firm lists 58 named physicians on its website, including specialists in cataract surgery, LASIK, glaucoma, retina, cornea, neurology, oculoplastics, and pediatrics. The wealth origin of the practice is not publicly disclosed. The practice offers a full spectrum of eye care services across more than 20 clinic locations in Tennessee. Its surgical offerings include ALLY Adaptive Cataract Treatment System by LENSAR, which combines AI-driven imaging with robotic-assisted precision, and the Light Adjustable Lens from RxSight, which allows postoperative adjustment of lens power. The firm also provides LASIK co-management, glaucoma treatment, dry eye therapy, and specialty disease management. Geographic footprint covers cities including Athens, Chattanooga, Clarksville, Cleveland, Columbia, Dayton, Franklin, Gallatin, Knoxville, Maryville, McMinnville, Morristown, Mt. Juliet, Murfreesboro, Nashville, North Nashville, Newport, Sevierville, Soddy Daisy, and Tullahoma. It also lists an Eye Surgery Center in Chattanooga, a Green Eye Surgery Center in Gallatin, and a SouthEast Eye Surgery Center in Knoxville (per firm website). The organization employs over 50 clinicians and maintains an administrative office reachable via email at info@seesgroup.com. No additional public filings disclose total patient volume, revenue, or assets under management. No recent operational events — such as new clinic openings, mergers, or leadership changes — were verifiable from the firm's public materials in the last 24 months. Southeast Eye Specialists differentiates structurally as a large, multi-specialty provider group in a consolidating regional market, with no disclosure of private-equity or institutional ownership. This opaque ownership structure is common among physician-led practices that have not announced outside investment, making the firm distinct from the many optometry chains backed by private capital.